Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02833246 · ClinicalTrials.gov registry record · NA

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

A NA study of Sarcoma and Lung, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02833246 is a NA study of Sarcoma and Lung that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 28 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02833246, a NA study of Sarcoma and Lung, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

Interventions

  • OTHER usual care
  • OTHER SMS/MMS text messaging

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2016-06-28
Est. Completion 2018-11-14
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT02833246

The ClinicalTrials.gov registry entry for NCT02833246 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Sarcoma appearing as the primary indexed condition, and to 2 interventions - of which usual care is the first listed.

NCT02833246 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02833246 about?

NCT02833246 is a clinical study titled "Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications". This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

What is the current status of trial NCT02833246?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2016-06-28. Estimated completion is 2018-11-14.

What conditions does trial NCT02833246 study?

This clinical trial studies the following conditions: Sarcoma, Lung, Solid Tumor Gastrointestinal.

What interventions are being tested in trial NCT02833246?

The interventions under investigation include: usual care (OTHER), SMS/MMS text messaging (OTHER).

Who is sponsoring clinical trial NCT02833246?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02833246 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.